4
Changes in Ownership
Summit Therapeutics Inc. Filed Acc 0001387131-22-008888
Chief Executive Officer bought 94,849,203 shares at $0.97 ($92,003,727)
From the SEC's structured data for this filing
Trades in this filing
DUGGAN ROBERT W · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-08-16 | Purchase : show line 1 in the form | +94,849,203 | $0.97 | $92,003,727 | 162,532,792 | D |
| Open-market purchases · 94,849,203 sh · avg $0.97 · $92,003,727 | ||||||
Loading xslF345X03/duggan-form4_081622.xml…